Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Benzydamine extented release - Camurus

Drug Profile

Benzydamine extented release - Camurus

Alternative Names: Benzydamine CR; CAM-2028; Episil; episil; episil® oral liquid; SP-03 - Camurus

Latest Information Update: 24 Oct 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Camurus
  • Developer Camurus; Meiji Seika Pharma; Solasia Pharma; Takeda Pharmaceuticals International GmbH
  • Class Analgesics; Anti-inflammatories; Antibacterials
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Stomatitis

Most Recent Events

  • 21 Oct 2019 Registered for Stomatitis in South Korea (Transmucosal)
  • 21 Oct 2019 Solasia Pharma intends to launch benzydamine (SP 03) in South Korea
  • 01 Jul 2019 Launched for Stomatitis in China (Transmucosal) before July 2019
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top